CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

86 filings reported holding CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share as of Q3 2024.
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 51.2M shares of 164M outstanding shares and own 31.2% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (7.81M shares), BVF INC/IL (5.23M shares), VANGUARD GROUP INC (5.16M shares), JANUS HENDERSON GROUP PLC (4.81M shares), ACADIAN ASSET MANAGEMENT LLC (3.1M shares), Prosight Management, LP (3.02M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3M shares), MILLENNIUM MANAGEMENT LLC (2.56M shares), Assenagon Asset Management S.A. (1.64M shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (1.52M shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.